# Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer

> **NCT00311623** · PHASE1,PHASE2 · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 32 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Rapamycin 3mg
- **DRUG:** Rapamycin 6mg
- **PROCEDURE:** Radical prostatectomy

## Key facts

- **NCT ID:** NCT00311623
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2008-01
- **Final completion:** 2010-06
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2019-02-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00311623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00311623, "Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00311623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*